Lv5
1070 积分 2021-08-02 加入
Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes
18小时前
待确认
A Comprehensive Review of Lysine-Specific Demethylase 1 and its Roles in Cancer
19小时前
待确认
Differentiation therapy revisited
19小时前
待确认
PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma
1个月前
已完结
The roles of Polycomb repressive complexes in mammalian development and cancer
1个月前
已完结
Context-specific Polycomb mechanisms in development
1个月前
已完结
Molecular landmarks of tumor hypoxia across cancer types
1个月前
已完结
HIF mediated and DNA damage independent histone H2AX phosphorylation in chronic hypoxia
1个月前
已完结
ScRNA-Seq Reveals a Distinct Osteogenic Progenitor of Alveolar Bone
2个月前
已完结
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
2个月前
已完结
皖公网安备34019202002308
